Diabetes Device

A continuous glucose monitoring system has the capability to connect directly with the Apple Watch for people with diabetes, according to a press release from Dexcom.

BOSTON — Continuous glucose monitoring has transformed the field of diabetes over the past 25 years. The technology can be used by both providers and people with diabetes to improve disease management, according to a speaker at ENDO 2024.

A miniature-sized automated insulin delivery system cleared by the FDA in 2023 is now compatible with a new-generation continuous glucose monitor, according to a press release.

The 2024 American Diabetes Association Standards of Care put an emphasis on getting continuous glucose monitoring into the hands of more people with diabetes.

Using a pod-based automated insulin delivery system can provide glycemic benefits for people with type 2 diabetes, according to a speaker at the International Conference on Advanced Technologies & Treatments for Diabetes.

The FDA cleared for marketing an over-the-counter continuous glucose monitor for adults with or without diabetes, according to an agency press release.

Making people with diabetes the center of all aspects of diabetes management is the focus of a new position statement published by the Endocrine Society.

The total annual cost of caring for Americans with diabetes in 2022 was an estimated $412.9 billion, and one in four total health care dollars in the U.S. went toward diabetes care, according to a report.

Children and adolescents with type 1 diabetes had an increase in time in range and reduction in HbA1c after starting a tubeless hybrid closed-loop insulin delivery system, according to study data

Hybrid closed-loop insulin delivery can increase time in range for pregnant women with type 1 diabetes with no safety concerns, according to trial findings presented at the European Association for the Study of Diabetes annual meeting.